Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer

Most Accessed Articles

New Anti-VEGF Drugs in Ophthalmology

Volume: 21   Issue: 12
Pp: 1194-1200
Claudio Campa *
DOI: 10.2174/1389450121666200428101738

Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer

Volume: 21   Issue: 3
Pp: 258-278
Ashish Ranjan Dwivedi, Amandeep Thakur, Vijay Kumar, Ira Skvortsova and Vinod Kumar*
DOI: 10.2174/1389450120666190821160730

Targeting Autophagic Pathways by Plant Natural Compounds in Cancer Treatment

Volume: 21   Issue: 12
Pp: 1237-1249
Fatemeh Forouzanfar and Seyed Hadi Mousavi*
DOI: 10.2174/1389450121666200504072635

Edaravone May Prevent Ferroptosis in ALS

Volume: 21   Issue: 8
Pp: 776-780
Snežana Spasić*, Aleksandra Nikolić-Kokić, Srđan Miletić, Zorana Oreščanin-Dušić, Mihajlo B. Spasić, Duško Blagojević and Zorica Stević
DOI: 10.2174/1389450121666200220123305

The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer

Volume: 21   Issue: 11
Pp: 1099-1104
Linqi Yang, Wenqi Zhang, Saiyam Chopra, Deeepjyot Kaur, Huibing Wang, Meng Li, Pingping Chen* and Wei Zhang*
DOI: 10.2174/1389450121666200504080112

N6-methyladenine RNA Modification (m6A): An Emerging Regulator of Metabolic Diseases

Volume: 21   Issue: 11
Pp: 1056-1067
Hui Zhong, Hui-Fang Tang and Yin Kai*
DOI: 10.2174/1389450121666200210125247

Application of Artificial Intelligence in Targeting Retinal Diseases

Volume: 21   Issue: 12
Pp: 1208-1215
Francesco Saverio Sorrentino, Giuseppe Jurman, Katia De Nadai, Claudio Campa, Cesare Furlanello and Francesco Parmeggiani*
DOI: 10.2174/1389450121666200708120646

IL-37 As a Potential Biotherapeutics of Inflammatory Diseases

Volume: 21   Issue: 9
Pp: 855-863
Junhui Bai, Yukun Li, Meixiang Li, Sijie Tan* and Daichao Wu*
DOI: 10.2174/1389450121666200429114926

Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies

Volume: 21   Issue: 9
Pp: 864-891
Devendra Kumar, Sahil Sharma, Sourav Kalra, Gurpreet Singh, Vikramdeep Monga and Bhupinder Kumar*
DOI: 10.2174/1389450121666200310115327

Anti-VEGF Treatment in Corneal Diseases

Volume: 21   Issue: 12
Pp: 1159-1180
Giuseppe Giannaccare, Marco Pellegrini, Cristina Bovone, Rossella Spena, Carlotta Senni, Vincenzo Scorcia and Massimo Busin*
DOI: 10.2174/1389450121666200319111710

Use of Anti-VEGF Drugs in Retinal Vein Occlusions

Volume: 21   Issue: 12
Pp: 1181-1193
Manuel AP Vilela*
DOI: 10.2174/1389450121666200428101343

Anti-VEGF and Retinal Dystrophies

Volume: 21   Issue: 12
Pp: 1201-1207
Maurizio Battaglia Parodi, Pierluigi Iacono* and Stefano Da Pozzo
DOI: 10.2174/1389450121666200428103334

Fluoroquinolones: Blessings Or Curses

Volume: 21   Issue: 13
Pp: 1354-1370
Priyanka P. Majalekar* and Pramodkumar J. Shirote
DOI: 10.2174/1389450121666200621193355

Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion

Volume: 22   Issue: 2
Pp: 192-201
Upinder Kaur, Sankha Shubhra Chakrabarti*, Bisweswar Ojha, Bhairav Kumar Pathak, Amit Singh, Luciano Saso and Sasanka Chakrabarti
DOI: 10.2174/1389450121666200924113243